Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China flag China · Delayed Price · Currency is CNY
5.38
-0.02 (-0.37%)
Apr 16, 2026, 3:04 PM CST
Market Cap4.05B +8.0%
Revenue (ttm)2.48B -1.7%
Net Income51.45M -12.5%
EPS0.07 -12.6%
Shares Out753.13M
PE Ratio78.76
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,191,248
Average Volume15,736,079
Open5.28
Previous Close5.40
Day's Range5.28 - 5.40
52-Week Range4.48 - 5.86
Beta0.56
RSI58.70
Earnings DateApr 18, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chron... [Read more]

Sector Healthcare
Founded 1999
Employees 2,267
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000931
Full Company Profile

Financial Performance

In 2024, SHE:000931's revenue was 2.53 billion, an increase of 11.22% compared to the previous year's 2.28 billion. Earnings were 53.59 million, an increase of 10.33%.

Financial Statements